Skip to main content
. 2019 Jun 2;10(14):3133–3139. doi: 10.7150/jca.30335

Table 1.

Demographic and clinical characteristics for ovarian cancer patients diagnosed with and without bone metastasis.

Subject characteristics No. of ovarian cancer patients (2010-2015) χ2 P-value
With BM (N=352, 1.09%) Without BM (N=31826, 98.91%)
Age, in years 16.29 <0.001
18-40 20(0.82) 2413(99.18)
41-64 151(0.91) 16417(99.09)
≥65 181(1.37) 12996(98.63)
Race 8.88 0.01
White 283(1.08) 25963(98.92)
Black 45(1.60) 2767(98.40)
Others 24(0.81) 2939(99.19)
Unknown 0(0.00) 157(100.00)
Marital status 7.97 0.01
Married 145(0.94) 15359(99.06)
Unmarried 193(1.27) 14982(98.73)
Unknown 14(0.93) 1485(99.07)
Insurance 0.36 0.55
Insured 326(1.07) 30140(98.93)
Uninsured 15(1.25) 1182(98.75)
Unknown 11(2.14) 504(97.86)
Laterality 5.01 0.08
Left 52(0.63) 8236(99.37)
Right 75(0.87) 8579(99.13)
Bilateral 63(0.62) 10093(99.38)
Unknown 162(3.19) 4918(96.81)
T stage 35.59 <0.001
T1 23(0.26) 8727(99.74)
T2 46(1.07) 4253(98.93)
T3 129(0.80) 16097(99.20)
Unknown 154(5.30) 2749(94.70)
N stage 74.84 <0.001
N0 134(0.59) 22550(99.41)
N1 111(1.70) 6426(98.30)
Unknown 107(3.62) 2850(96.38)
Grade 20.69 <0.001
4(0.17) 2336(99.83)
7(0.21) 3331(99.79)
66(0.76) 8618(99.24)
34(0.54) 6314(99.46)
Unknown 241(2.10) 11227(97.90)
Histology 41.37 <0.001
Serous 87(0.58) 14815(99.42)
Non-serous 205(1.30) 15609(98.70)
Unknown 60(4.10) 1402(95.90)
CA-125 6.02 0.01
Normal 15(0.52) 2853(99.48)
Elevated 215(0.99) 21441(99.01)
Unknown 122(1.59) 7532(98.41)
Lung Met 642.95 <0.001
None 207(0.69) 29879(99.31)
Yes 127(6.87) 1722(93.13)
Unknown 18(7.41) 225(92.59)
Liver Met 606.90 <0.001
None 200(0.67) 29636(99.33)
Yes 136(6.24) 2043(93.76)
Unknown 16(9.82) 147(90.18)
Brain Met 460.19 <0.001
None 301(0.94) 31705(99.06)
Yes 20(24.69) 61(75.31)
Unknown 31(34.07) 60(65.93)
Sur(pri) 526.89 <0.001
None 250(3.63) 6645(96.37)
Yes 99(0.39) 25132(99.61)
Unknown 3(5.77) 49(94.23)

Abbreviations: BM=bone metastases; CA-125 = cancer antigen 125; Met=metastases; Sur(pri)=surgical treatments on primary site.